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Dear Editor,
Sometimes, given the similarity of initial symptoms,
diagnostic confusion may arise between demyelinating
disease and stroke. Misdiagnosis of MS likely occurs
more frequently and has been documented well [1, 2].
However, as far as we know, demyelinating diseases
treated with thrombolysis have never been reported
before. We present two inflammatory demyelinating





A 28-year-old woman was admitted with right-side weak-
ness for 50 min. Neurological examination showed right
nasolabial fold flattening and 1 of 5 strength in the right
limbs. Initial head CT revealed low density on the left
periventricular area. Cerebral MRI scan showed a long T1
and T2 signal intensity lesion on the left periventricular
area, which had restricted diffusion on diffusion weighted
imaging (DWI) (Fig. 1). She was diagnosed as acute
ischemic stroke and treated with intravenous thrombolysis
4 h after onset.
She improved gradually. Neurological examination only
showed hemiparesis of the right 16 h later. Her past history
was not remarkable.
Hospital course
Results of blood work including biochemical, immunologic
and infectious assessment were normal except for mild
elevated triglycerides. Magnetic resonance angiography
(MRA) was normal.
However, her strength worsened 5 days after throm-
bolysis. Neurologic examination showed right central
facial palsy and 2 of 5 strength in the right limbs. With a
deteriorating clinical status, we suspected the diagnose of
stroke. Lumbar puncture revealed a clear fluid liquid with
normal cellularity and mild elevated protein. AQP 4-anti-
body (AQP4-Ab) was negative in blood and CSF. Contrast-
enhanced MRI showed a gadolinium (Gd) enhancement
lesion on the left posterior lateral ventricle angle which had
a long T1 and T2 signal intensity (Fig. 2). The lesion
showed a defined ring structure suggestive of Balo´’s con-
centric sclerosis (BCS). After this finding, the diagnosis
was revised to BCS. Other investigations were performed
to support the diagnosis. Her cervical and thoracic spine
MRI were normal.
Intravenous of methylprednisolone (1 g/day for 5
days) was initiated followed by oral treatment. She
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Fig. 1 Brain MRI of case 1 showed a long T2 (a) signal intensity lesion on the left periventricular area, which had restricted diffusion on DWI
(b)
Fig. 2 Contrast-enhanced MRI of case 1 showed a Gd enhancement lesion on the left posterior lateral ventricle angle which had long T1 signal
intensity




A 56-year-old woman began to hiccup and vomit fre-
quently 3 months ago, which progressively worsen over 1
month, combined with dysphagia and hoarseness. Brain
MRI of local hospital revealed long signal intensity on T1
and T2 weighted imaging involving the dorsolateral
medullary, which had restricted diffusion on DWI, and
MRA was unremarkable (Fig. 3). She was diagnosed as
stroke and treated with aspirin. 30 days after onset, she
suddenly deteriorated with flaccid paralysis of the right
limbs, with 1 of 5 strength. Cerebral arterial angiography
was performed in local hospital and she was treated with
intra-arterial urokinase in right vertebral artery. Her con-
dition improved 3 days after thrombolysis and she could
walk by herself 10 days later.
One month later, she abruptly developed left hemi-
paresis. Brain and cervical MRI revealed long signal
intensity lesion on T1 and T2-weighted imaging involving
the hypothalamic, periaqueductal, medulla and cervical
medullary (Fig. 4).
She had an upper respiratory tract infection 1 week prior
to onset. Her past history was not remarkable except for
well-controlled hypertension.
Hospital course
Cranial nerve examination was remarkable for bilateral
torsional nystagmus, left nasolabial fold flattening and
decreased sensation in the left. Motor examination revealed
1 of 5 in the left limbs. Blood work were normal. CSF
electrophoresis demonstrated oligoclonal bands with a high
IgG index. AQP4-Ab was positive (1:10) both in blood and
CSF. Thoracic spine MRI studies did not reveal any
abnormality. A diagnosis of neuromyelitis optica spectrum
disorder was made based on Wingerchuk’s criteria
(myelitis associated with brain lesions typical of neu-
romyelitis optica).
Intravenous of methylprednisolone (1 g/day) was initi-
ated and then converted to oral after 5 days. Azathioprine
was then added. She gradually recovered 3 days after
treatment and could walk by herself 20 days later.
Follow-up
Cerebral MRI performed 7 months later did not show any
new lesions, and the dorsolateral medullary lesion had
significantly reduced in size (Fig. 5). She has not experi-
enced any clinical relapses during the follow-up period.
Discussion
The necessity for rapid thrombolysis in acute ischemic
stroke may lead to treatment of patients with conditions
mimicking stroke. It is remarkable that both of the two
patients got relieved in a short time after thrombolysis. The
patient in case 1 improving in 4.5 h made diagnosis more
difficult. It needs to be questioned whether the patient of
case 2 should receive intra-arterial thrombolysis according
to the indications [3], whatever, she recovered in short
time.
Recent studies suggest that fibrinogen plays an
important role not only in coagulation but also in
inflammation [4]. Some authors reported that thrombin
activity preceded onset of neurological signs, increased at
disease peak, and correlated with fibrin deposition,
microglial activation, demyelination, axonal damage, and
clinical severity [4]. The role of coagulation-fibrinolysis
system in experimental autoimmune encephalomyelitis
(EAE) was confirmed using batroxobin, the thrombin
inhibitor. They reported that batroxobin treatment
Fig. 3 Brain MRI of local hospital in case 2 revealed long signal intensity involving the dorsolateral medullary on T2 weighted imaging (a),
which had restricted diffusion on DWI (b), and her MRA was unremarkable (c)
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suppressed clinical signs of cell transferred EAE, and
deposition of fibrin around the vessels in the spinal cord
was markedly suppressed in batroxobin-treated rats. These
findings suggest that batroxobin suppresses EAE by pre-
venting fibrin deposition, and provide evidence that CNS-
associated deposition of fibrin and ensuing fibrinolysis,
together with increased permeability of blood brain bar-
rier (BBB), are related prerequisites for the clinical
manifestation of EAE [5]. Using mice deficient in tissue-
type plasminogen activator (tPA-/-), East et al. inves-
tigated the involvement of the PA system on the clinical
and pathological features of EAE. They found that
tPA-/- mice suffered an early and a more severe acute
disease characterized by incomplete recovery when
compared to wild-type controls [6]. A better understand-
ing of the mechanism of inhibition of coagulation-fibri-
nolysis system facilitate disease pathogenesis may present
a new strategy for pharmacological intervention in
inflammatory demyelinating diseases.
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